HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.

Abstract
Min mice have a germ-line nonsense mutation at codon 850 of the adenomatous polyposis coli (Apc) gene. These mice spontaneously develop multiple polyps in the small and large intestine at the age of 10-12 weeks. The aim of this study was to assess the role of reactive nitrogen species and poly(ADP-ribose) synthetase in tumorogenesis. Oxidative stress was found to be increased in the mucosa of the small intestine of Apc(min/+) mice with a concomitant increase in intestinal polyposis over control mice. Pharmacological inhibition of inducible nitric oxide synthase (NOS) with guanidinoethyldisulfide (GED) or stimulation of the breakdown of the nitrogen reactive species peroxynitrite using a potent decomposition catalyst, FP 15, reduced both the intestinal tumor load and the oxidative stress associated with intestinal polyposis in Apc(min/+) mice. Surprisingly, pharmacological inhibition of poly(ADP-ribose) synthetase by the phenanthridinone derivative PJ 34 also reduced the intestinal polyposis and oxidative stress in these mice, possibly through the inhibition of induction of nitric oxide synthase. These results suggest that reactive nitrogen species particularly peroxynitrite play a pivotal role in development of intestinal polyposis and that strategies to reduce both the oxidative stress and the formation of these radical species may be potential chemopreventive approaches for colorectal cancers.
AuthorsJon G Mabley, Pál Pacher, Peter Bai, Rebecca Wallace, Sunali Goonesekera, Laszlo Virag, Garry J Southan, Csaba Szabó
JournalMutation research (Mutat Res) Vol. 548 Issue 1-2 Pg. 107-16 (Apr 14 2004) ISSN: 0027-5107 [Print] Netherlands
PMID15063141 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Enzyme Inhibitors
  • Guanidines
  • N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride
  • Phenanthrenes
  • Poly(ADP-ribose) Polymerase Inhibitors
  • bis(2-guanidinoethyl)disulfide
  • Peroxynitrous Acid
  • Poly Adenosine Diphosphate Ribose
  • Nitric Oxide
  • Malondialdehyde
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Poly(ADP-ribose) Polymerases
  • Metalloproteases
Topics
  • Animals
  • Colon (enzymology)
  • Enzyme Inhibitors (pharmacology)
  • Genes, APC (physiology)
  • Guanidines (pharmacology)
  • Intestinal Mucosa (enzymology)
  • Intestinal Polyps (genetics, metabolism, therapy)
  • Male
  • Malondialdehyde (metabolism)
  • Metalloproteases (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Nitric Oxide Synthase Type II
  • Oxidative Stress
  • Peroxynitrous Acid (metabolism)
  • Phenanthrenes (pharmacology)
  • Poly Adenosine Diphosphate Ribose (metabolism)
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: